Published in Semin Arthritis Rheum on June 01, 1999
Quantitative salivary gland scintigraphy can distinguish patients with primary Sjøgren's syndrome during the evaluation of sicca symptoms. Clin Rheumatol (2007) 1.48
Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration. Ann Rheum Dis (2005) 0.87
The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study. Clin Rheumatol (2007) 0.81
Characterization of cognitive dysfunction in Sjögren's syndrome patients. Clin Rheumatol (2013) 0.81
High prevalence of hepatitis C antibody and RNA in patients with Sjögren's syndrome. Semin Arthritis Rheum (2000) 0.75
Mucin 5B in saliva and serum of patients with oral lichen planus. Sci Rep (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med (1969) 6.16
Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med (1978) 4.28
Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome. Arthritis Rheum (1976) 4.02
The pathogenesis of autoimmunity in New Zealand black mice. Curr Top Microbiol Immunol (1974) 3.98
The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol (1974) 3.82
Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes. J Immunol (1968) 3.81
Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol (1985) 3.31
Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med (1967) 2.92
Xerostomia in Sjögren's syndrome. Evaluation by sequential salivary scintigraphy. JAMA (1971) 2.89
Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice. J Exp Med (1969) 2.78
Impaired Lymphocyte Transformation and Delayed Hypersensitivity in Sjögren's Syndrome. J Clin Invest (1967) 2.77
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum (1988) 2.77
Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum (1971) 2.66
Disordered immunologic regulation and autoimmunity. Transplant Rev (1976) 2.62
Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J Exp Med (1981) 2.46
Fractionation of splenic antibody-forming cells on glass bead columns. J Immunol (1967) 2.41
B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum (1988) 2.37
Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest (1977) 2.33
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
Synergy among lymphoid cells mediating the graft-versus-host response. I. Synergy in graft-versus-host reactions produced by cells from NZB-Bl mice. J Exp Med (1970) 2.15
DNA-binding assay for detection of anti-DNA antibodies in NZB-NZW F1 mice. J Immunol (1969) 2.13
beta-Estradiol reduces natural killer cells in mice. J Immunol (1978) 2.02
The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol (1972) 2.01
Filter radioimmunoassay for antibodies to reovirus RNA in systemic lupus erythematosus. Arthritis Rheum (1974) 1.92
Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol (1981) 1.89
Establishment and characterization of a murine hybridoma secreting monoclonal anti-DNA autoantibody. J Immunol (1980) 1.88
Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol (1984) 1.81
Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice. Immunology (1977) 1.80
The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement. Ann Intern Med (1969) 1.79
The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol (1972) 1.74
Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. Arthritis Rheum (1968) 1.72
The oral component of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol (1975) 1.70
Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med (1971) 1.70
The pathogenesis of autoimmunity in New Zealand mice. 3. Factors influencing the formation of anti-nucleic acid antibodies. Immunology (1971) 1.68
Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis (1980) 1.64
T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome. J Clin Invest (1974) 1.63
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med (1970) 1.58
SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol (1995) 1.57
Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med (1978) 1.54
Response of NZB and NZB-NZW spleen cells to mitogenic agents. J Immunol (1970) 1.54
Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome. J Clin Invest (1980) 1.52
Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities. J Clin Invest (1986) 1.48
Immunoglobulin synthesis by salivary gland lymphoid cells in Sjögren's syndrome. J Clin Invest (1970) 1.44
Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest (1979) 1.43
Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. Arthritis Rheum (1981) 1.41
Sjögren's syndrome. Bull Rheum Dis (1966) 1.41
Lymphocyte classes in New Zealand mice. II. Decreased frequency of immunoglobulin-bearing lymphocytes and increased frequency of lymphocytes lacking detectable theta or immunoglobulin determinants. J Immunol (1972) 1.39
Measurements of ultracold-neutron lifetimes in solid deuterium. Phys Rev Lett (2002) 1.38
IgM and IgG antibodies to DNA, RNA, and DNA:RNA in systemic lupus erythematosus. Clin Immunol Immunopathol (1975) 1.35
Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum (1979) 1.33
Effects of neonatal thymectomy and splenectomy on survival and regulation of autoantibody formation in NZB/NZW F1 mice. J Immunol (1977) 1.32
Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. Am J Med (1972) 1.32
Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum (1997) 1.30
VH sequence of a human anti-Sm autoantibody. Evidence that autoantibodies can be unmutated copies of germline genes. J Immunol (1989) 1.30
Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its inteaction with an IgG-reactive monoclonal IgM. J Clin Invest (1971) 1.29
The role of NZB-NZW F1 thymus in experimental tolerance and auto-immunity. Arthritis Rheum (1970) 1.27
Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Arthritis Rheum (1976) 1.26
Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen. J Clin Invest (1982) 1.25
Antibodies to a DNA:RNA hybrid in systemic lupus erythematosus measured by a cellulose ester filter radioimmunoassay. Nat New Biol (1972) 1.24
Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon. J Immunol (1979) 1.22
Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun (2006) 1.22
Natural killer cells, bone, and the bone marrow: studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice. J Immunol (1979) 1.21
Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies. J Clin Invest (1975) 1.19
Evidence for an abnormal microenvironment in the thymus of New Zealand black mice. J Immunol (1975) 1.19
Thymosin corrects the abnormal DNA synthetic response of NZB mouse thymocytes. Proc Natl Acad Sci U S A (1974) 1.19
Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. N Engl J Med (1975) 1.19
Murine amyloid. II. Transfer of an amyloid-accelerating substance. Arthritis Rheum (1969) 1.19
Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases. J Clin Invest (1976) 1.17
Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol (1993) 1.17
Interleukin 2 enhances natural killing of normal lymphocytes. Cell Immunol (1984) 1.17
Surface antigens on mouse natural killer cells: use of monoclonal antibodies to inhibit or to enrich cytotoxic activity. J Immunol (1981) 1.17
Rapid loss of tolerance induced in weanling NZB and B-W F1 mice. Science (1969) 1.16
Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. Semin Arthritis Rheum (1996) 1.15
Estrogen induces normal murine CD5+ B cells to produce autoantibodies. J Immunol (1989) 1.14
The pathogenesis of autoimmunity in New Zealand mice. II. Acceleration of glomerulonephritis by polyinosinic-polycytidylic acid. Lab Invest (1970) 1.14
Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci (2007) 1.14
Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. Clin Immunol Immunopathol (1983) 1.13
Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis. Science (1975) 1.13
Autoimmunity and the immunologic network. Arthritis Rheum (1978) 1.12
The age related responses of New Zealand mice to a murine sarcoma virus. Clin Exp Immunol (1971) 1.11
Altered K+ channel expression in abnormal T lymphocytes from mice with the lpr gene mutation. Science (1986) 1.11
Inhibition of antigodies binding polyinosinic-polycytidylic acid in human and mouse lupus sera by viral and synthetic ribonucleic acids. J Clin Invest (1971) 1.10
Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases. Arthritis Rheum (1971) 1.10
Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol (1994) 1.08
Mouse macroglobulin antibody to sheep erythrocytes: a non-complement-fixing type. J Immunol (1968) 1.08
Thymus-antigen- and immunoglobulin-positive lymphocytes in tissue infiltrates of NZB/NZW mice. Clin Immunol Immunopathol (1974) 1.07
Significance of self-recognition and interleukin-2 for immunoregulation, autoimmunity and cancer. Scand J Immunol (1982) 1.07
Polyamine oxidation down-regulates IL-2 production by human peripheral blood mononuclear cells. J Immunol (1989) 1.05
Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol (1999) 1.04
Marrow granulocyte reserves in the rheumatic diseases. Arthritis Rheum (1973) 1.04
Objective and subjective sleep disturbances in patients with rheumatoid arthritis. A reappraisal. Arthritis Rheum (1994) 1.04
Effects of short-term administration of sex hormones on normal and autoimmune mice. J Immunol (1985) 1.04
Tolerance to polyinosinic-polycytidylic acid in NZB-NZW mice. Science (1970) 1.03
Cellular interactions in lymphocyte proliferation: effect of syngeneic and xenogeneic macrophages. Cell Immunol (1976) 1.03
Type C virus expression and host response in diet-cured NZB/W mice. Nature (1977) 1.03
Lymphocyte classes in New Zealand mice. I. Ontogeny and mitogen responsiveness of thymocytes and thymus-derived lymphocytes. J Immunol (1972) 1.03
Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) (1996) 1.02